FDA Approves New Labeling For HeartMate 3 LVAD That Says Aspirin Is No Longer Recommended To Help Patients With Heart Failure Avoid Post-Implant Blood Clots
- August 22, 2024
You must be logged in to access this content.
Health Law Daily
You must be logged in to access this content.